Vimta Labs (524394) Q4 99/00 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 99/00 earnings summary
28 Oct, 2026Executive summary
Returned to profitability after three years, with operating profit of Rs.93.98 lakh before interest and depreciation and net profit of Rs.7.37 lakh on turnover of Rs.410.92 lakh.
IDBI accepted a one-time settlement; the full Rs.410.42 lakh was paid by August 3, 2000, clearing the IDBI term loan debt.
Financial highlights
Operating revenue was Rs.410.92 lakh, up from Rs.294.01 lakh in FY1998-99; domestic testing and analysis contributed Rs.405.97 lakh and exports Rs.4.95 lakh.
Net profit was Rs.7.37 lakh, versus a net loss of Rs.264.17 lakh in the prior year; profit before amortization and prior-period adjustments was Rs.20.46 lakh.
Finance charges fell to Rs.31.09 lakh from Rs.196.39 lakh; depreciation was Rs.42.43 lakh, versus Rs.42.32 lakh.
Outlook and guidance
Current-year performance was described as encouraging; a state-level franchise scheme had launched, with a nationwide rollout planned.
Laboratory Information Management Systems (LIMS) were installed to improve efficiency from sample management through reporting; the franchise network was expected to expand customer access.
Latest events from Vimta Labs
- Q2 income grew 9.9% as biologics began commercial delivery.524394
Q2 26/27 - Turnover fell and losses emerged, while GLP certification strengthened export prospects.524394
Q4 96/97 - Recession drove a Rs 219.81 lakh loss as new inspection services offered growth potential.524394
Q4 97/98 - Record turnover and higher profit, with equipment upgrades and export growth in focus.524394
Q4 00/01 - Turnover surged 75%, with record exports and expansion plans supporting the outlook.524394
Q4 01/02 - Revenue rose 81%, exports surged, and a fivefold capacity expansion was planned.524394
Q4 03/04 - FY03 growth surged as exports expanded and lab capacity investment accelerated.524394
Q4 02/03 - Net profit rose 66% as exports surged and major lab expansion advanced.524394
Q4 04/05 - Capacity-constrained growth drove expansion, with FY06/07 revenue targeted at Rs.90–100 crore.524394
Q4 05/06